secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001562762-23-000208
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q1 net sales up 20% to $276.7M; non-GAAP EPS $0.53
-----------------------------------------------------------------

- Worldwide net sales $276.7M, up 20% YoY (21% constant currency); GAAP net income $49.1M.
- GAAP diluted EPS $0.48; non-GAAP diluted EPS $0.53, up 24.7% YoY.
- U.S. Spine sales up 14%; Enabling Technologies grew 91% to $25M.
- Full-year 2023 guidance reaffirmed: net sales $1.1B, non-GAAP diluted EPS $2.30.
- Pending merger with NuVasive received shareholder approvals from both companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000208/0001562762-23-000208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000208/gmed-20230504x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-23-000208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer